Replies to post #73558 on NanoViricides Inc. (NNVC)

[BonelessCat]

While it is fun to speculate on what a bidding war might bring, the best value to investment in the biopharma sector takes place after Phase 2 success and certainly not before proof of safety in humans.

Pharmaset (bought out for $11 billion following Phase 2) acquisition and every other deal worth considering where financing was not an issue, did not take any offers while still pre-clinical. NNVC now has how much money in the bank?

[FORZANANO]

T

herefore, it would not surprise me that we soon experience a couple of large pharmas bidding on this relative small but groundbreaking biotech; possibly before the "Tox"?

Small for now!

NNVC have managed their tests on animals successfully where other large known companies have not succeeded.

Yes I agree with you NNVC will attract large pharmas.
I don't know what NNVC will do when that will happen.

But they have the power! That's mean that they are unique and better with their results.

FN